Fri, Oct 24, 2014, 11:05 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Abraxas Petroleum Corp. Message Board

micro00 29 posts  |  Last Activity: Oct 22, 2014 9:36 AM Member since: Mar 13, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • micro00 micro00 Oct 22, 2014 9:36 AM Flag

    heavy buying by institutions to fill out positions

  • micro00 micro00 Oct 22, 2014 9:27 AM Flag

    If you're a hospital why would you buy any if the company was running out of cash and could go away? Now with cash and a viral platform, would hope hospitals start buying. we'll find out next qtr.

  • Reply to

    Price Target $1.50 , Rating Buy

    by seeyouatthetop68 Oct 22, 2014 8:59 AM
    micro00 micro00 Oct 22, 2014 9:02 AM Flag

    raised $20 mil, sold 40 million shares to institutional investors.@.50.someone took a HUGE position with that many shares issued

  • Reply to

    morning note

    by micro00 Oct 7, 2014 8:47 AM
    micro00 micro00 Oct 7, 2014 2:07 PM Flag

    another street comment of interest:
    This particular ruling (ie. the preliminary injunction), would not result in immediate
    dollars to NLST. Rather, if the judge grants the injunction, we believe that Diablo
    would have the right to appeal (a process that could take an additional 9 months) but
    that the preliminary injunction on shipments would remain in effect unless Diablo
    was able to obtain specific relief suspending that order. If not, any customers of IBM,
    Huawei, and Sandisk (among others) that had received units would need to return
    them and no additional shipments could be made. The brand damage that can occur
    from such an action has led some companies to settle.

  • Reply to

    morning note

    by micro00 Oct 7, 2014 8:47 AM
    micro00 micro00 Oct 7, 2014 10:14 AM Flag

    Morning note is a wall street analyst summary, not my opinion. Just passing on.

  • micro00 by micro00 Oct 7, 2014 8:47 AM Flag

    For a preliminary injunction to be granted, it must demonstrate 4 points, along with NLST’s claims to each point:
    1) Claim is likely to succeed on its merits
    a. NLST’s contract clearly stipulates that Diablo could not use the devices that it implemented using NLST’s trade secrets with disabling key functionality (specifically, load isolation and rank multiplication)
    b. NLST has direct evidence that Diablo used the devices in early demos with certain customers (we believe the evidence comes from the whistleblowers and corroborated by testimony from Diablo mgmt.)
    c. NLST’s expert witness demonstrates that the Diablo product stole 19 specific trade secrets (specific testimony redacted)
    d. Diablo filed a patent application only a few weeks after receiving NLST confidential information, disclosing trade secrets.
    2) Plaintiff would suffer irreparable harm
    a. NLST cited two examples of companies who declined to work with it due to disputed IP.
    b. Industry experts agree that Vault and UlltraDIMM address overlapping markets
    3) The balance of equities tips in its favor, and
    a. NLST claims that granting the injunction would only serve to enforce the contract as written between the two parties
    4) Injunction would be in the public interest
    a. Breach of confidentiality and sale of stolen technology are actions the public has an interest in stopping

    Other notes from the filing of great interest to NLST investors:
    • Netlist said a new Vault product to an unnamed customer (redacted) in March 2014, and expects quantities with ship with tens of thousands of units annually for the next 5 years. We believe this claim refers to its hyperscale customer, which we believe is Microsoft.
    o This is consistent with our expectations in terms of units, and the commentary about expecting to generate units for 5 years provides a lot of certainty in terms of gross profit generation.
    There are significant redactio

  • Reply to

    Q4 Results

    by coalporter123 Sep 15, 2014 5:31 PM
    micro00 micro00 Sep 15, 2014 6:31 PM Flag

    Agree with revs of $17 but if you look at net income avail to common shareholders/weighted average shares outstanding then go through the last Q (9 months income statement) you get:
    Q1: .37
    Q2: .33
    Q3: .26
    Q4: .23

    to get fiscal 2014 of $1.19 (reported $1.58) excluding $2.3 mil tax benefit (.39)
    Fiscal 2013 also included a $2.3m tax benefit

    Q4 y/y was
    $17m vs $18.3 m
    Income from continuing operations $2.6m vs $2.3m

    Still comes down to a real cheap stock even if you assume a flat line in eps

  • This morning, TEAR announced interim results of a multi-center dry eye disease (DED) prevalence study being carried out at four hospitals in the U.K.

    We believe that the results of this study are extremely positive for TEAR, increasing the potential that the TearLab osmolarity test will eventually be adopted by the UK’s National Health Service (NHS).

    • The study compared the effectiveness of the TearLab osmolarity test as compared to other traditional methods of diagnosing dry eye disease (DED).
    • The interim results showed that of all the tests used, osmolarity had the highest correlation to actual disease
    • The study also found that ‘traditional’ methods of detecting dry eye do not work well. Of particular note is the fact that ~20% of patients with significant symptoms had no other sign of dry eye except for hyperosmolarity and the fact that without an osmolarity test doctors were only able to diagnose 34 of these symptomatic patients (~28%) with dry eye disease.
    • The implication from these results is that implementation of osmolarity testing could potentially improve diagnosis, and reduce cost, within the NHS. The current practice in the NHS is for symptomatic patients to visit a general practitioner, who would then refer that patient on to an ophthalmologist at a cost of approximately $60 per visit. Even then, the tests being performed by the ophthalmologist are generally ineffective. An alternative practice might be to have the GP’s accurately diagnose DED using the TEARLAB test and avoiding the ophthalmology referral altogether.

  • micro00 micro00 Sep 3, 2014 5:56 PM Flag

    Guess you didnt realize how lumpy E&C is when you bought. Look at MTZ and MG also. Big misses, stocks get hit, then bounce back. Backlog is true indicator of whats going to happen to the stock.

  • micro00 micro00 Sep 3, 2014 5:46 PM Flag

    Record backlog and about .05 of integration expenses in Q4. Company always gives conservative guidance at the beginning of the year.

  • Reply to

    Meat and Potatoes

    by locatedmyballs Aug 27, 2014 4:36 PM
    micro00 micro00 Aug 27, 2014 5:08 PM Flag

    Take out all the #$%$ and use GAAP and tax rate of 35% you get $.15 vs $.01 Y/Y. Very good growth.

  • micro00 micro00 Aug 26, 2014 10:21 AM Flag

    Cant happen with Libby...anti-trust. Libby tried to buy them years ago and justice dept killed it as it would create #$%$ monopoly

  • after big short position causes financial ruin

  • micro00 by micro00 Aug 21, 2014 10:00 AM Flag

    ooohhhhhhh must hurt real bad. Guess you wont be sitting down for awhile....

  • Reply to


    by expert_stock Aug 21, 2014 9:43 AM
    micro00 micro00 Aug 21, 2014 9:52 AM Flag

    not HUGE news but good news that Sam is starting to fix this POS

  • micro00 by micro00 Aug 21, 2014 9:27 AM Flag

    Sam's just getting started

  • micro00 by micro00 Aug 12, 2014 5:28 PM Flag

    "significant opportunity above previous expectations" referring to contract win with leading server company. PO starting by end of year.

  • Reply to


    by tdbloodstock3 Aug 12, 2014 11:54 AM
    micro00 micro00 Aug 12, 2014 12:45 PM Flag

    its a shelf not an offering...they could say a billion shares and warrants..doesnt mean they'll issue them. You think Gary is going to severly dilute his position?

  • Reply to

    explanation of short selling

    by mo1973ca Jul 31, 2014 11:17 AM
    micro00 micro00 Jul 31, 2014 11:27 AM Flag

    No way would a guy who posts 105 times since July 17 about fraud and SEC investagations be a liar, right?

  • Reply to

    Don't bet against Sam..stocks will be a lot higher

    by micro00 Jul 31, 2014 10:46 AM
    micro00 micro00 Jul 31, 2014 11:11 AM Flag

    He doesnt take a job unless he's got free reign and I dont think the Clinton Group and Monomoy hired him to do anything but to fix their investment.

4.04-0.09(-2.18%)Oct 24 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
SodaStream International Ltd.
NasdaqGSFri, Oct 24, 2014 4:00 PM EDT
Digital River Inc.
NasdaqGSFri, Oct 24, 2014 4:00 PM EDT